Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: BoE chief lifts FTSE 100; Disney up in New York

Thu, 09th Feb 2023 16:58

(Alliance News) - London's FTSE 100 hit another record high on Thursday as largely soothing words from the Bank of England governor lifted the mood, while equities in New York joined in on the action, with Walt Disney a star performer.

The blue-chip index retreated from its fresh intraday high of 7,949.57 points, though it did achieve a new closing record. There was little joy elsewhere in London, however, as mid and small-cap measures ended lower.

The FTSE 100 index ended up 25.98 points, or 0.3%, at 7,911.15. The FTSE 250 index, however, fell 26.47 points, or 0.1%, at 20,277.34. The AIM All-Share closed down 2.39 points, or 0.3%, at 880.84.

The Cboe UK 100 ended up 0.5% at 792.32, the Cboe UK 250 lost 0.3% at 17,707.17, and the Cboe Small Companies fell 0.1% to 14,144.35.

In European equities on Thursday, the CAC 40 index in Paris closed up 1.0%, while the DAX 40 in Frankfurt ended up 0.7%.

Policymakers at the Bank of England have said inflation is almost "guaranteed" to come down rapidly this year unless there is a new, unexpected global event.

Andrew Bailey, the bank's governor, told MPs during the Treasury Committee that he is "concerned" about the continued persistence of inflation, but expects the rate to halve this year.

He said: "We are concerned about persistence. This is why we raised interest rates at this time. I'm very uncertain, particularly about pricing and wages, and we have the largest upside force we've ever had on inflation. We do put weight on the persistent risks, but there are also very powerful downside forces this year."

Bailey insisted that there would be a "very powerful unwinding" of inflation throughout the year, which would only be derailed if there is a new external shock, like a development in the Ukraine war, that it cannot foresee.

Silvana Tenreyo, an external member of the bank's nine-person Monetary Policy Committee, stressed that declining inflation is all but guaranteed.

The euro stood at USD1.0750 at the time of European equities close on Thursday, higher against USD1.0734 on Wednesday. The pound was quoted at USD1.2154, higher compared to USD1.2084. Against the yen, the dollar was trading at JPY131.10, lower compared to JPY131.29.

The dollar was weaker after a rise in US jobless claims.

In the week that ended February 4 - this past Saturday - the advance figure for seasonally adjusted initial claims was 196,000. This represents an increase of 13,000 from the previous week's unrevised total of 183,000.

London's FTSE 100 was supported by gains from Standard Chartered and pharmaceutical firm AstraZeneca. There were falls for gambling firm Entain and British American Tobacco, however.

Standard Chartered jumped 11% on a report that First Abu Dhabi Bank is pressing ahead with a potential USD35 billion offer for the London-based lender.

According to Bloomberg, FAB's proposed acquisition of Standard Chartered is still in play, after a move to put earlier takeover plans on hold "didn't halt its ambitions to become a global financial powerhouse".

AstraZeneca added 4.1%. The pharmaceutical firm posted a swing to profit in 2022, despite ending the year with a slightly weaker fourth quarter.

Revenue in 2022 rose by 19% to USD44.35 billion from USD37.42 billion a year before, or by 24% at constant currency. AstraZeneca swung to a pretax profit of USD2.50 billion from a loss of USD265 million, while core earnings per share jumped 26% to USD6.66.

Earnings from BAT disappointed. The cigarette maker reported a marginal rise in profit for 2022, amid an "increasingly challenging" economic environment, but it noted that momentum in its New Category was "strong".

The London-based maker of Dunhill, Kent and Lucky Strike cigarettes said pretax profit was up just 1.7% to GBP9.32 billion in 2022 from GBP9.16 billion in 2021. Annual revenue grew 7.7% to GBP27.65 billion from GBP25.68 billion.

The stock closed down 2.4%.

While StanChart got a boost from possible M&A action, Labdrokes owner Entain plunged 14% as one-time suitor and current joint-venture partner MGM Resorts ruled out a deal.

In an earnings call on Wednesday, US casino operator MGM Resorts International squashed any speculation of a potential takeover.

"The simple answer on Entain is no; we've moved on," said MGM Chief Executive Bill Hornbuckle, later adding: "We value the relationship with Entain. We value BetMGM."

Elsewhere in London, Watches of Switzerland slid 11% as a fall in jewellery sales overshadowed otherwise decent third-quarter results.

The luxury watch retailer said revenue rose 17% year-on-year to GBP407 million from GBP348 million. However, jewellery revenue alone fell 2% year-on-year to GBP41 million.

"The company may be taken aback at the scale of the negative reaction to what were otherwise reasonably robust third quarter numbers accompanied by reiterated guidance. It suggests a degree of scepticism over its claims to be relatively insulated from weaker consumer demand thanks to a wealthier clientele and the continuing strong demand for luxury watches," AJ Bell analyst Russ Mould commented.

Elsewhere in London, Deliveroo rose 0.1%. The food delivery company plans to axe about 350 roles, amid a slowdown in the number of people ordering takeaways. It is understood the majority of the cuts will affect UK-based employees, PA reported.

The delivery firm's founder, Will Shu, told staff on Thursday that it will cut 9% of roles, as it became the latest tech business to cut jobs. Deliveroo said it expects the total number of workers to be made redundant to be "closer to 300" due to redeployments elsewhere in the business.

After also announcing job cuts, Walt Disney climbed 1.6% in New York. The entertainment company will lay off 7,000 workers, Chief Executive Robert Iger said on a call to analysts on Wednesday. It will be one of his first major decisions since returning to the role.

It is targeting USD5.5 billion worth of cost savings. The company's share price rise on Thursday suggests investors are impressed by Iger's more austere approach. Former boss Bob Chapek spent two years as CEO, a period that saw Wall Street concerned about rising expenses at the company.

Stocks in New York were higher at the time of the closing bell in London on Thursday. The Dow Jones Industrial Average and the S&P 500 index were up 0.2%. The Nasdaq Composite was up 0.3%.

Brent oil was quoted at USD83.73 a barrel late Thursday in London, down from USD84.01 late Wednesday. Gold was quoted at USD1,873.46 an ounce, down against USD1,878.10.

Friday's economic events calendar has inflation data from China overnight, before a UK gross domestic product reading at 0700 GMT.

The local corporate events calendar has a trading statement from speciality chemicals firm Victrex and annual results from insurer Lancashire Holdings.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.